EP3078369A1 — Coated tablet formulation and method
Assigned to AstraZeneca AB · Expires 2016-10-12 · 10y expired
What this patent protects
The present invention refers to a coated tablet comprising a tablet core; an inner seal coating layer coated on the tablet core, wherein the inner seal coating layer comprises at least one coating layer polymer; a second coating layer coated on the inner seal coating layer, where…
USPTO Abstract
The present invention refers to a coated tablet comprising a tablet core; an inner seal coating layer coated on the tablet core, wherein the inner seal coating layer comprises at least one coating layer polymer; a second coating layer coated on the inner seal coating layer, wherein the second coating layer comprises saxagliptin or a pharmaceutically acceptable salt thereof and at least one coating layer polymer, and optionally a third outer protective coating layer coated on the second coating layer, wherein the third outer protective coating layer comprises at least one coating layer polymer.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.